Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 41, 2007 - Issue 3
Submit an article Journal homepage
54
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy

Dragomir P. Zubac Section of Urology, Department of Surgery, The Gade Institute, Haukeland University Hospital, Bergen, NorwayCorrespondence[email protected]
,
Leif Bostad Department of Pathology, The Gade Institute, Haukeland University Hospital, Bergen, Norway
,
Charlotta Gestblom Clinic of PathologyCentral Hospital Karlstad, Karlstad, Sweden
,
Björn Kihl Clinics of Surgery and Urology, Central Hospital Karlstad, Karlstad, Sweden
,
Tomas Seidal Clinic of PathologyCentral Hospital Karlstad, Karlstad, Sweden
,
Tore Wentzel-Larsen Centre for Clinical Research, Haukeland University Hospital, Bergen, Norway
&
August M. Bakke Section of Urology, Department of Surgery, The Gade Institute, Haukeland University Hospital, Bergen, Norway
 show all
Pages 191-197 | Received 24 May 2006, Published online: 09 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Colin H Richards, Zahra Mohammed, Tahir Qayyum, Paul G Horgan & Donald C McMillan. (2011) The Prognostic Value of Histological Tumor Necrosis in Solid Organ Malignant Disease: A Systematic Review. Future Oncology 7:10, pages 1223-1235.
Read now
Sandra Pflanz, Sabine Brookman-Amissah, Jan Roigas, Friederike Kendel, Bernd Hoschke & Matthias May. (2008) Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma. Scandinavian Journal of Urology and Nephrology 42:6, pages 507-513.
Read now

Articles from other publishers (14)

Kvetoslava Peckova, Petr Martinek, Kristyna Pivovarcikova, Tomas Vanecek, Reza Alaghehbandan, Kristyna Prochazkova, Delia Perez Montiel, Milan Hora, Faruk Skenderi, Monika Ulamec, Pavla Rotterova, Ondrej Daum, Jiri Ferda, Whitney Davidson, Ondrej Ondic, Magdalena Dubova, Michal Michal & Ondrej Hes. (2017) Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases. Annals of Diagnostic Pathology 26, pages 23-30.
Crossref
Brett Delahunt, Hemamali Samaratunga & Diane N. Kenwright. (2016) Histologic prognostic markers for renal cell neoplasia. Diagnostic Histopathology 22:2, pages 65-72.
Crossref
Hui-Ming Jiang, Jin-Huan Wei, Zhi-Ling Zhang, Yong Fang, Bang-Fen Zhou, Zhen-Hua Chen, Jun Lu, Bing Liao, Fang-Jian Zhou, Jun-Hang Luo & Wei Chen. (2015) Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis. International Urology and Nephrology 48:2, pages 191-199.
Crossref
Christine M. Lohse, Sounak Gupta & John C. Cheville. (2015) Outcome prediction for patients with renal cell carcinoma. Seminars in Diagnostic Pathology 32:2, pages 172-183.
Crossref
Miguel Villalobos-Gollás, Bernardo Aguilar-Davidov, Carolina Culebro-García, Martha O. Gómez-Alvarado, Priscila Rojas-Garcia, Raúl Ibarra-Fombona, Norma Uribe-Uribe, Guillermo Feria-Bernal, Ricardo Castillejos-Molina, Mariano Sotomayor, Fernando Gabilondo & Francisco Rodríguez-Covarrubias. (2012) Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols. International Urology and Nephrology 44:5, pages 1369-1374.
Crossref
Dragomir P Zubac, Tore Wentzel-Larsen, Tomas Seidal & Leif Bostad. (2010) Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy. BMC Urology 10:1.
Crossref
Andrew B. RosenkrantzBenjamin E. NiverErin F. FitzgeraldJames S. BabbHersh ChandaranaJonathan Melamed. (2010) Utility of the Apparent Diffusion Coefficient for Distinguishing Clear Cell Renal Cell Carcinoma of Low and High Nuclear Grade. American Journal of Roentgenology 195:5, pages W344-W351.
Crossref
Ju-Han Lee, Jung-Woo Choi & Young-Sik Kim. (2010) The Value of Histologic Subtyping on Outcomes of Clear Cell and Papillary Renal Cell Carcinomas: A Meta-analysis. Urology 76:4, pages 889-894.
Crossref
Matthew D. Katz, Maria F. Serrano, Robert L. Grubb, Ted A. Skolarus, Feng Gao, Peter A. Humphrey & Adam S. Kibel. (2010) Percent Microscopic Tumor Necrosis and Survival After Curative Surgery for Renal Cell Carcinoma. Journal of Urology 183:3, pages 909-914.
Crossref
Dragomir P. Zubac, Leif Bostad, Björn Kihl, Tomas Seidal, Tore Wentzel-Larsen & Svein A. Haukaas. (2009) The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival. Journal of Urology 182:5, pages 2144-2149.
Crossref
Tobias Klatte, Jonathan W. Said, Michela de Martino, Jeffrey LaRochelle, Brian Shuch, Jian Yu Rao, George V. Thomas, Fairooz F. Kabbinavar, Arie S. Belldegrun & Allan J. Pantuck. (2009) Presence of Tumor Necrosis is Not a Significant Predictor of Survival in Clear Cell Renal Cell Carcinoma: Higher Prognostic Accuracy of Extent Based Rather Than Presence/Absence Classification. Journal of Urology 181:4, pages 1558-1564.
Crossref
Dragomir P Zubac, Leif Bostad, Tomas Seidal, Tore Wentzel-Larsen & Svein A Haukaas. (2008) The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy. BMC Urology 8:1.
Crossref
D. P. ZUBAC, L. BOSTAD, B. KIHL, J. EIDE, T. WENTZEL‐LARSEN & S. A. HAUKAAS. (2008) Organ‐confined clear cell renal cell carcinoma: the prognostic impact of microvascular invasion, nuclear grade and tumour size . APMIS 116:12, pages 1027-1033.
Crossref
Maria F. Serrano, Matthew Katz, Yan Yan, Adam S. Kibel & Peter A. Humphrey. (2008) Percentage of high‐grade carcinoma as a prognostic indicator in patients with renal cell carcinoma. Cancer 113:3, pages 477-483.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.